CORDIS Project

Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders

NEUROFGL·278006·FP7

Funding breakdown and partner intelligence are Premium

Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1

Upgrade

Start free • Cancel anytime • 14-day refund guarantee

View on CORDIS

Funding data

Programme: FP7
Participants: 4
Start - End: 01/01/2012 — 31/12/2014
Status: CLOSED

Summary

NeuroFGL aims to advance a novel regenerative therapy for neurodegenerative disorders by developing early clinical assessment tests and refining patient selection. This project focuses on improving the development process for therapies targeting conditions like Alzheimer's disease and traumatic brain injury, enhancing…

Full AI summary and premium intelligence

Upgrade to Premium for the complete AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Objective

Neurodegenerative disorders such as, Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), stroke, Traumatic Brain Injury (TBI) and chronic stress create a major economic burden to society and a substantial reduction in quality of life for patients and families.

The development of neuroregenerative therapies is notoriously difficult and requires significant investment.

NeuroFGL will contribute to decrease these barriers through: (1) the clinical advancement of a promising novel regenerative…

Full objective and premium intelligence

Upgrade to Premium for the complete objective, AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Coordinator

UCPH

KOBENHAVNS UNIVERSITET

Country: Denmark, Kobenhavn
Organization type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No

Network and participants(4 participants)

Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.

ENKAM
Denmark, COPENHAGEN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
participant
FORENAP
France, ROUFFACH
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
participant
H. LUNDBECK AS
Denmark, Valby
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
participant
QUAL
France, Marseille
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
participant

4 participants shown of 7

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Partner & research intelligence

Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.

Consortium analytics and research context are Premium

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

CORDIS call / funding scheme

Call: —
Sub call: FP7-HEALTH-2011-two-stage
Funding scheme: CP-FP - Small or medium-scale focused research project
Domain note: This block describes the CORDIS project call context. Live open opportunities are managed in the Funding & Tenders domain.

Fields of Science (EuroSciVoc)

Guests see up to 5 EuroSciVoc fields.

Medical and health sciencesBasic medicineNeurologyDementiaAlzheimer
Medical and health sciencesBasic medicineNeurologyStroke
Natural sciencesBiological sciencesBiochemistryBiomolecules
Natural sciencesBiological sciencesNeurobiology

Topic

Guests see up to 5 topics.

HEALTH.2011.1.4-1

Sector

Guests see up to 5 sectors.

Health & Biotech